After a 4 to 6 weeks run-in period which placebo was given like a single blind manner, patients were randomly assigned to carvedilol or atenolol.
After a 4- to 6-week run-in period during which placebo was given in a single-blind manner, patients were randomly assigned to carvedilol or atenolol.